![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 33, 31177-31183, August 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
¶
||
** 

From the
Laboratory for Alzheimer's Disease &
Aging Research, the ||Molecular Biology Research
Laboratory, the **Neurobiology Research Laboratory,
Veterans Affairs Medical Center, Kansas City, Missouri 64128, and the
Departments of
Neurology and

Pharmacology, Toxicology, and
Therapeutics, University of Kansas School of Medicine, Kansas City, Kansas
66170
We have previously reported that thrombin, the ultimate serine protease in
the coagulation cascades, is a proinflammatory agent that causes proliferation
and activation of brain microglial cells. However, participation of its
principal receptor, the protease-activated receptor 1 (PAR1) appears to be
limited to promoting microglial proliferation and not induction of
inflammatory mediators. In the present study, we now report that thrombin
action in promoting inflammatory mediators from brain microglia is mediated
through another thrombin receptor, PAR4. Here we show that the PAR4 agonist
peptide (PAR4AP, GYPGKF), but not the PAR1AP (TRAP, SFLLRN), induced tumor
necrosis factor-
(TNF-
) production not only in cultured murine
microglial cells in vitro but also in rat cortex in vivo.
Down-regulation of PAR4 expression in microglial cultures by a specific
antisense, but not a sense, oligonucleotide reduced PAR4AP-induced
TNF-
. Mechanistic studies indicated that, in comparison with PAR1
signaling, prolonged increase of
[Ca2+]i and phosphorylation of
p44/42 mitogen-activated protein kinases, as well as NF
B activation may
be responsible for PAR4AP-induced TNF-
production in microglia. Taken
together, these results demonstrate that PAR4 activation mediates the
potentially detrimental effects of thrombin on microglia, implying that
perspectives of exploiting PAR1 as a potential anti-inflammatory target should
be shifted toward PAR4 as a much more specific therapeutic target in brain
inflammatory conditions associated with neurotrauma and
neurodegenerations.
Received for publication, February 28, 2003 , and in revised form, May 2, 2003.
* This work was supported by the Medical Research and Development Service, Department of Veterans Affairs (to Z. S., B. A. C., and B. W. F.), a grant (to Z. S.) from the Missouri Alzheimer's Research Fund, a grant (to B. A. C.) from the Alzheimer's Association and resources from the Midwest Biomedical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Laboratory for Alzheimer's Disease & Aging Research, Veterans Affairs Medical Center, 4801 Linwood Blvd., Kansas City, MO 64128. Tel.: 816-861-4700 (ext. 7084); Fax: 816-922-3375; E-mail: zsuo{at}kumc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Yang, S. Song, Y. Hua, T. Nakamura, R. F. Keep, and G. Xi Effects of Thrombin on Neurogenesis After Intracerebral Hemorrhage Stroke, July 1, 2008; 39(7): 2079 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Choi, J. K. Ryu, S. U. Kim, and J. G. McLarnon Modulation of the Purinergic P2X7 Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain J. Neurosci., May 2, 2007; 27(18): 4957 - 4968. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Nicole, A. Goldshmidt, C. E. Hamill, S. D. Sorensen, A. Sastre, P. Lyuboslavsky, J. R. Hepler, R. J. McKeon, and S. F. Traynelis Activation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain Injury J. Neurosci., April 27, 2005; 25(17): 4319 - 4329. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.-K. Hanisch, D. van Rossum, Y. Xie, K. Gast, R. Misselwitz, S. Auriola, G. Goldsteins, J. Koistinaho, H. Kettenmann, and T. Moller The Microglia-activating Potential of Thrombin: THE PROTEASE IS NOT INVOLVED IN THE INDUCTION OF PROINFLAMMATORY CYTOKINES AND CHEMOKINES J. Biol. Chem., December 10, 2004; 279(50): 51880 - 51887. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rohatgi, F. Sedehizade, K. G. Reymann, and G. Reiser Protease-Activated Receptors in Neuronal Development, Neurodegeneration, and Neuroprotection: Thrombin as Signaling Molecule in the Brain Neuroscientist, December 1, 2004; 10(6): 501 - 512. [Abstract] [PDF] |
||||
![]() |
Z. Suo, M. Wu, B. A. Citron, G. T. Wong, and B. W. Festoff Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early {beta}-Amyloid Accumulation J. Neurosci., March 31, 2004; 24(13): 3444 - 3452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Suo, M. Wu, B. A. Citron, R. E. Palazzo, and B. W. Festoff Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling J. Biol. Chem., September 26, 2003; 278(39): 37681 - 37689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |